ABSTRACT: Dynamic turnover of cell-surface glycans is involved in a myriad of biological events, making this process an attractive target for in vivo molecular imaging.
Introduction
Metabolic oligosaccharide engineering (MOE) coupled with the bioorthogonal chemical reporter strategy has opened an avenue for labeling and visualizing glycans in living organisms. [1] [2] [3] [4] [5] In this approach, the cell's glycan biosynthetic machinery is exploited to install a biorthogonal chemical group onto cell surface glycans, which is then covalently labeled in a secondary step with a complementary probe. 6 However, this strategy has a few intrinsic limitations, such as the biocompatibility of a chosen bioorthogonal reaction and poor deep-tissue penetration of the probes. 7 Chemoenzymatic glycan editing, however, enables the direct incorporation of a fluorescently labeled monosaccharide without the requirement of a second-step covalent reaction. By using recombinant sialyltransferases (STs) and fucosyltransferases (FTs) with broad donor substrate scopes, sialic acid (Sia) and fucose (Fuc) conjugated with fluorescent dyes can be directly transferred to the cell surface from the corresponding nucleotide sugars. [8] [9] [10] [11] Furthermore, recent findings have shown that fluorescently labeled trehalose and N-acetylglucosamine can be directly incorporated into the cell wall of M. tuberculosis 12 and intracellular O-GlcNAcylated proteins in cultured mammalian cells 13 , respectively. Inspired by these findings, here, we sought to explore the feasibility of directly incorporating fluorophore-labeled monosaccharides into the cellular glycans of living organisms by exploiting the substrate promiscuity of endogenous glycosyltransferases (Fig. 1a) .
Results and Discussion
We assessed the incorporation of fluorophore-labeled monosaccharides in the live zebrafish embryo due to its optical transparency, external fertilization, and amenability to genetic and embryological manipulations. [14] [15] [16] First, we synthesized a fluorophore-labeled CMP-N-acetylneuraminic acid (CMP-Neu5NAc (Fig. s1 ). Confirming that STs had the capability to incorporate probe A onto cell-surface glycans for the single-step glycan labeling.
Next, we microinjected probe A into the yolk sack of zebrafish embryos at the one-cell stage, 25 which enables the injected nucleotide sugar to disperse and incorporate into all daughter cells during early zebrafish embryogenesis (Fig. 2a) . The injected embryos were subsequently imaged using fluorescent microscope at distinct developmental stages. As shown in the supplemental Fig. s2 , overwhelming fluorescent signals in the yolk due to the accumulation of probe A prevented the visualization of the incorporated Sia in other tissue structures during the early embryogenesis. To our delight, the incorporation of probe A in several distinct tissue structures became apparent starting at 14 hours' post fertilization (hpf), and 28 hpf. Importantly, the probe-dependent Cy5 signal in live embryos is significantly reduced by coinjection of sialylation inhibitor 3FaxNeu5Ac 26 or natural sialylation precursor CMP-Neu5Ac with probe A (Fig. s3) , suggesting specific labeling of cell-surface glycans in zebrafish.
To confirm that probe A was metabolically incorporated into zebrafish glycoproteins, the lysates of the 24 hpf deyolked embryos were analyzed using an in-gel fluorescence assay.
We detected strong A-dependent Cy5 signal in SDS-PAGE resolved proteins with a molecular weight ranging from 30-250 kD ( Fig. 2b and s4 ), which was subsequently removed by PNGase F-assisted releasing of N-glycans or neuraminidase-directed hydrolyzing Sia from glycoproteins ( Fig. s5) . Together, these results strongly suggest that CMP-Sia-sulfo-Cy5 is metabolically incorporated in sialylated glycoproteins.
Once we confirmed the specific labeling of probe A into the cell-surface glycoproteins, we proceeded to perform systematic imaging of sialylation in zebrafish tissues at 24 hpf.
We observed distinct Cy5 fluorescence in the head and trunk regions ( The ability to simultaneously visualize distinct biomolecules in vivo is of essential importance for understanding normal and disease processes. We then evaluated the feasibility to visualize sialylated and fucosylated glycans in parallel. To this end, we co-injected probe A and probe C at a 1:1 molar ratio into the yolk of zebrafish embryos and conducted confocal imaging at different time points (Fig. 4a and s12 ). As shown in Fig. 4a , sialylated glycans have broader distributions than fucosylated counterparts at 24
hpf embryos. The blood vessel is the region showing the strongest co-localization of both glycans. However, these two types of glycans also exhibit many distinct distribution patterns. For example, sialylation was abundantly detected in the notochord and myotome region, while fucosylation was generally localized in the vascular network. In addition, the labeled fucoside decayed at a much faster rate than the labeled sialosides; by 72 hpf, the Cy3-associated signal disappeared almost completely in the brain; whereas abundant Cy5 signal was still detectable at this time (Fig. s13) .
Next, we directly compared the labeling patterns of the single-step glycan labeling to the two-step bioorthogonal chemical reporter strategy previously well-established. We co-injected probe C and GDP-FucAz into the same embryo, and the metabolically incorporated FucAz was fluorescently labeled with Al-sulfo-Cy5 by BTTPS-assisted CuAAC reaction at 24 hpf. In deep tissues such as the cht region, we only observed the Cy3 signal, but not that of Cy5. Likewise, only a very weak Cy5 signal was detected in the trunk and head regions, which is likely due to the poor permeability of labeling reagents into the deep-tissue of live zebrafish embryos. The observation that a much stronger Cy5 signal was detected at the tip of the tail compared to the Cy3 signal is likely caused by the same issue (Fig. s14) . Similar results were also observed in probe C and GDP-FucAl coinjected zebrafish embryos (Fig. s15) .
To exclude the possibility that the observed labeling patterns were generated by unincorporated probes circling in the blood or diffusing into the tissue matrix, a hematopoietic mutant line known as 'Cloche' 27 was used to repeat our labeling experiments. In this mutant (cloche-/-), no blood circling system including cht, is formed due to the failure to specify all blood cell types in the developing embryos. We injected embryos from cloche mutant heterozygous (cloche+/-) parents with probe A or C. A distinct labeling pattern was detected in the trunk and head regions of wildtype-like sibling embryos (cloche+/-) that has normal hemato-vascular cell types, as we had previously observed. In the cloche-/-embryos that are easily distinguished by the lack of blood flow after 26 hpf, the loss of the labeling was observed in tissues such as cht due to the loss of vascular development (Fig. 4b, c, movie s8-s11 ). Based on these observations, we reasoned that the background fluorescence generated by the free, unincorporated probes in the bloodstream is negligible.
The cht region is a transient vascular network formed by the ramification of the caudal vein plexus, provides a necessary niche microenvironment for supporting the development of nascent hematopoietic stem cells (HSCs). 28 The cht is of critical importance for the maturation of these blood cell and immune cell types. To explore the possible biological functions of glycans within this compartment, we imaged probe A and probe C-injected zebrafish in the background of hematopoietic marker Tg(cMyb:eGFP) 29 whose HSCs produced by definitive hematopoiesis can be tracked by the expression of eGFP (Fig. 4d, embryos with an anti-CLA antibody (Fig. 4d) . Despite the high fluorescence background, the intensive staining within the cht region was predominantly found in the extracellular matrix, rather than co-localizing with HSCs. This observation strongly suggests that the interactions mediated by sialylated and fucosylated glycans such as sLe X are involved in the hematovascular cell biology in zebrafish.
During these imaging studies, we made an intriguing observation: compared to their sibling embryos (cloche+/-), the incorporation of GDP-Fuc based Probe C was significantly decreased in the mutant embryos (cloche-/-); whereas the incorporation of CMP-Sia-based probe A was essentially unchanged (Fig. 4b and 4c) . Interestingly, compared to the untreated or the probe A injected groups approximately 5-fold more cloche-/-mutant embryos were still alive at 48 hpf in the probe C-microinjected group (Fig. s16a) . These observations prompted us to examine the expression of fucoside biosynthesis enzymes in the cloche mutants. We performed RT-qPCR analysis of gene expression of key components of the GDP-Fuc de novo biosynthesis and salvage pathways (Fig. s17a) , and found that the mRNA levels of fucose kinase (FUK) and GDP-Fuc transporter (SLC35C1) were significantly downregulated in the cloche mutants (cloche-/-) (Fig. s17b) . Consistent with those changes, the global fucosylation in cloche-/-embryos was significantly down-regulated compared to that of the wildtype embryos or their siblings (cloche+/-) as assessed by fluorescein-conjugated Aleuria Aurantia Lectin (AAL-FITC) staining (AAL is a lectin specific for α 1-3-and α 1-6-linked fucose) (Fig.   5a ). By administering GDP-Fuc into embryos of the cloche mutants (cloche-/-) at the one-cell stage, the global fucosylation level can be largely rescued (Fig. 5b ).
All vertebrates, including zebrafish, has two waves of hematopoiesis 32, 33 The earlier of these is known as the primitive wave and the later one as the definitive wave. The primitive wave is responsible for the production of red blood cell types that can facilitate tissue oxygenation as the embryo undergoes rapid growth; whereas definitive or adult hematopoiesis provides the organism with long-term HSCs that are capable of unlimited self-renewal and generating all mature hematopoietic lineages. The cloche mutant (cloche-/-) exhibits serious defects in both waves, but interestingly the absence of vascular cells is partially rescued by 48 hpf. 27 To try and decipher the role that fucosylation might play during early zebrafish hematopoietic development, we injected Fuc or GDP-Fuc into transgenic zebrafish lines harboring reporters of these two stages of hematopoiesis and followed their development.
Although no convincing findings were made using reporter lines of the primitive wave, in the transgenic zebrafish line Tg(cMyb:eGFP) whose definitive blood progenitors can be directly traced by eGFP-expression, Fuc and GDP-Fuc injection distinctively increased the population of eGFP-labeled HSCs in the cht niche region between 48-72 hpf. These changes were not detectable in mock and CMP-Neu5Ac administrated groups ( Fig. 5c and 5d). Finally, we also identified significantly larger number of live cloche-/-mutant embryos 48 hpf after the administration of Fuc or GDP-Fuc compared to CMP-Neu5Ac-treated or mock-treated groups (Fig. s16b) .
Discussion
Previous studies by Bertozzi and us demonstrated that unnatural UDP-GalNAc bearing an azide tag and GDP-fucose bearing an azide or alkyne tag can be used by endogenous ppGalNActransferases and fucosyltransferases, respectively, and incorporated into cellular glycoconjugates in zebrafish embryos 34, 35 Bioorthogonal chemistry can then be employed for their visualization as early as at the two-cell stage. Via this approach, rapid glycan migration to the cleavage furrow of mitotic cells was observed despite poor tissue penetration of fluorescent probes used for their detection.
In the current study, we have demonstrated that fluorophore-tagged CMP-sialic acid and GDP-fucose (probes A-C) injected into the yolk of zebrafish embryos are incorporated onto cellular glycoconjugates, enabling the direct deep-tissue visualization of sialylated and fucosylated glycans. Using this single-step approach, time lapse, high-resolution, and sensitive confocal imaging of these biologically important glycans in zebrafish embryogenesis is realized. Importantly, this approach enables direct visualization of the dynamic turnover of glycans in live embryos. For example, we observed that in the head region, fucosylatd glycans have a quicker turnover rate than sialylated glycans. 24, 36, 37 Studies by Stanley, Haltiwanger, and Taniguchi have shown that knockout of FUT8, POFUT1 or POFUT2 is lethal to mice. [38] [39] [40] [41] In addition, congenital mutations of the Golgi localized GDP-fucose transporter SLC35C1 cause leukocyte adhesion deficiency type II, whose manifestation is severe developmental and immune deficiencies. 42 In line with these previous observations, we discovered that cloche mutation leads to down-regulation of fuk and slc35c1, and accordingly reduced cell-surface fucosylation, which can be partially compensated by exogenously introduced Fuc or GDP-Fuc. Interestingly, not only did Fuc or GDP-Fuc injection expand the HSC-population in the cht niche, but this treatment also increased the survival of the cloche mutant significantly. Our findings combined with previous reports [43] [44] [45] [46] underscore the critical role of fucosylation in hematopoiesis, especially in the definitive wave, though the exact molecular mechanism for our observed phenotypes is still waiting to be further explored.
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